Chemical Structure : Ranibizumab
CAS No.:
Catalog No.: PC-Ab1063Not For Human Use, Lab Use Only.
Ranibizumab (Lucentis, RG-6321) is a specific affinity-matured, recombinant, humanized, anti-VEGF antigen-binding antibody fragment (Fab) that binds and neutralizes all the biologically active forms of VEGF-A, an important mediator in the development of choroidal neovascularisation. Ranibizumab was approved by the Food and Drug Administration (FDA) for the treatment of neovascular AMD..
Packing | Price | Stock | Quantity |
---|---|---|---|
1 mg | $358 | In stock | |
5 mg | $758 | In stock | |
10 mg | $1280 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Ranibizumab (Lucentis, RG-6321) is a specific affinity-matured, recombinant, humanized, anti-VEGF antigen-binding antibody fragment (Fab) that binds and neutralizes all the biologically active forms of VEGF-A, an important mediator in the development of choroidal neovascularisation. Ranibizumab was approved by the Food and Drug Administration (FDA) for the treatment of neovascular AMD.
M.Wt | ||
Formula | Human IgG1-Kappa | |
Appearance | Solid | |
Storage |
|
|
Solubility |
PBS, pH 7.0 Contains no stabilizers or preservatives |
|
Chemical Name/SMILES |
|
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright